Mar 26, 2021 | False Claims Act, Government Investigations, Health Care
In an address at the Federal Bar Association’s Qui Tam Conference, Acting Assistant Attorney General Brian Boynton discussed the DOJ Civil Division’s current False Claims Act (FCA) enforcement priorities. Although not the full universe of cases the that the DOJ will...
Mar 26, 2021 | General, Government Investigations
Over the past several years, the laws governing medical and recreational use of cannabis have gone through a significant transformation. Since 2012, fifteen states and the District of Columbia have legalized recreational use of marijuana. Still, marijuana remains...
Mar 4, 2021 | COVID-19 Related Law, Government Investigations, Health Care
On February 25, 2021, the U.S. Department of Health and Human Services (“HHS”) announced the resolution of three complaints alleging that MedStar Health Hospitals (“MedStar”) refused disabled patients access to support persons. According to HHS Office of Civil Rights...
Feb 17, 2021 | COVID-19 Related Law, Fraud Investigations, Government Investigations, Medicare and Medicaid, White Collar Crime
On February 11, 2021, the U.S. Department of Justice (“DOJ”) announced the first criminal charges for the misappropriation of funds designated for medical providers during the COVID-19 pandemic. According to the press release, Ms. Amina Abbas owned a home health...
Feb 12, 2021 | False Claims Act, Government Investigations, Health Care
The Department of Justice recently announced that Athenahealth, Inc. (Athena), an electronic health record (“EHR”) vendor, has agreed to pay $18.25 million to settle claims that it violated the False Claims Act (“FCA”). Athena allegedly implemented various marketing...
Jan 11, 2021 | COVID-19 Related Law, Government Investigations, Health Care
The U.S. District Court for the Southern District of Georgia issued a permanent injunction barring Matthew Ryncarz and his companies, Fusion Health and Vitality LLC (d/b/a Pharm Origins) and Fusion Ionz LLC (also d/b/a Pharm Origins), from selling unapproved drugs. ...
